Stephen Parent
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2021First federal award
$3.2MFederal grants as PI6 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
6 awards · $3.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 25, 2026 | NIH | SBIR Phase II Novel Broad Spectrum Inhibitors of Dihydrofolate Reductase (DHFR) for Treatment of Infections from High Threat Fungal Pathogens | $995K | KATHERA BIOSCIENCE INC. |
| Jun 4, 2025 | NIH | SBIR Phase II Novel Broad Spectrum Inhibitors of Dihydrofolate Reductase (DHFR) for Treatment of Infections from High Threat Fungal Pathogens | $995K | KATHERA BIOSCIENCE INC. |
| Jul 31, 2024 | NIH | SBIR Phase I A Redesigning Existing Drugs against Indispensable Targets (ReEDIT) platform technology for discovery of novel drugs to treat fungal infections | $299K | KATHERA BIOSCIENCE INC. |
| Jan 2, 2024 | NIH | SBIR Phase II Novel Broad Spectrum Inhibitors of Dihydrofolate Reductase (DHFR) for Treatment of Infections from High Threat Fungal Pathogens | $299K | KATHERA BIOSCIENCE INC. |
| Aug 11, 2023 | NIH | SBIR Phase I A Redesigning Existing Drugs against Indispensable Targets (ReEDIT) platform technology for discovery of novel drugs to treat fungal infections | $299K | KATHERA BIOSCIENCE INC. |
| Jun 17, 2021 | NIH | SBIR Phase I Ess1: A pathogenic fungal target for a novel class of broad-spectrum therapeutic agents | $299K | KATHERA BIOSCIENCE INC. |
Peer ranks
Federal funding#563
Awards as PI#315
Patents#273
Companies
- KATHERA BIOSCIENCE INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.